Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5

Jorge Abreu-Gomez1, Daniel Walker1, Tareq Alotaibi1

  • 1Department of Medical Imaging, The Ottawa Hospital, University of Ottawa, 1053 Carling Avenue, C1 Radiology, Ottawa, Ontario, K1Y 4E9, Canada.

European Radiology
|March 27, 2020
PubMed
Abstract

Insights

Prostate MRI observation size, but not ADC values, correlates with higher pathological stage in PI-RADS 4 and 5 lesions. Larger sizes also indicate higher Gleason scores, aiding in prostate cancer assessment.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Prostate Imaging Reporting and Data System (PI-RADS) v2.1 categorizes MRI findings.
  • Higher PI-RADS scores (4 and 5) indicate a higher likelihood of clinically significant prostate cancer.
  • Understanding pathological features associated with these scores is crucial for treatment planning.

Purpose of the Study:

  • To compare observation size and apparent diffusion coefficient (ADC) values in PI-RADS v2.1 category 4 and 5 prostate MRI observations.
  • To correlate these imaging metrics with adverse pathological features such as extra-prostatic extension (EPE), seminal vesicle invasion (SVI), and Gleason score (GS).

Main Methods:

  • Retrospective analysis of 267 men with 3-T MRI before radical prostatectomy.
  • Two blinded radiologists assigned PI-RADS v2.1 scores; discrepancies resolved by consensus.
  • A third radiologist measured observation size and ADC metrics (ADC.mean, ADC.min, ADC.ratio).
  • Statistical analysis included t tests, ANOVA, Pearson correlation, and ROC analysis to compare imaging findings with pathological outcomes.

Main Results:

  • Observation size, but not ADC metrics, was associated with pathological stage (EPE and SVI).
  • Size thresholds of ≥15 mm and ≥19 mm optimized accuracy for detecting EPE and SVI, respectively.
  • Larger observation size, lower ADC.min, and lower ADC.ratio were associated with higher Gleason scores.
  • Size correlated better with higher Gleason scores than ADC metrics.

Conclusions:

  • In PI-RADS v2.1 category 4 and 5 observations, tumor size is a significant predictor of higher pathological stage.
  • ADC metrics did not correlate with pathological stage but showed differences when stratified by Gleason score.
  • Observation size is a valuable imaging biomarker for assessing the aggressiveness of high-risk prostate cancer lesions.